RANI Rani Therapeutics Holdings,...

Nasdaq ranitherapeutics.com


$ 1.82 $ -0.27 (-12.92 %)    

Friday, 24-Oct-2025 19:59:04 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 1.82
$ 2.03
$ 1.82 x 7,190
$ 1.90 x 3,470
$ 1.76 - $ 2.18
$ 0.39 - $ 3.87
12,411,904
na
130.8M
$ 0.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-06-2024 03-31-2024 10-Q
7 03-20-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-22-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-16-2021 09-30-2021 10-Q
17 09-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 4-biotech-stocks-lifting-off-as-momentum-builds

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...

 hc-wainwright--co-assumes-rani-therapeutics-hldgs-at-buy-announces-price-target-of-11

HC Wainwright & Co. analyst Brandon Folkes assumes Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy rating and announces...

 maxim-group-maintains-buy-on-rani-therapeutics-hldgs-raises-price-target-to-10

Maxim Group analyst Michael Okunewitch maintains Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy and raises the price targe...

 rani-teams-up-with-chugai-to-revolutionize-oral-drug-delivery-for-rare-diseases

Rani Therapeutics (NASDAQ: RANI) stock surged on licensing collaboration with Chugai and $60.3M private placement. RANI up 191....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION